Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M70,390Revenue $M23,113Net Margin (%)20.3Z-Score4.4
Enterprise Value $M70,586EPS $4.3Operating Margin %23.2F-Score5
P/E(ttm))20.0Cash Flow Per Share $5.4Pre-tax Margin (%)25.5Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %12.7Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %0.4Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow9.1y-y EBITDA Growth Rate %-25.8ROA % (ttm)13.3Higher Current Ratio y-yY
Dividend Yield %3.1Insider Buy (3m)1ROE % (ttm)26.6Less Shares Outstanding y-yY
Payout Ratio %62.0Shares Outstanding M1,119ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 636%New holding, 50441 sh.50,441
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 636%Reduce -3.98%21,982,700
LLYJohn Hussman 2014-06-30 Reduce-0.02%$58.21 - $63.1
($59.62)
$ 636%Reduce -50%5,000
LLYRay Dalio 2014-06-30 Sold Out -0.02%$58.21 - $63.1
($59.62)
$ 636%Sold Out0
LLYPRIMECAP Management 2014-03-31 Add0.37%$50.73 - $59.85
($55.61)
$ 6313%Add 10.83%57,129,708
LLYJoel Greenblatt 2014-03-31 Reduce-0.16%$50.73 - $59.85
($55.61)
$ 6313%Reduce -93.61%9,016
LLYRay Dalio 2014-03-31 Reduce-0.01%$50.73 - $59.85
($55.61)
$ 6313%Reduce -34.83%31,439
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 6326%Add 22.98%22,895,000
LLYCharles Brandes 2013-12-31 Add0.19%$47.65 - $51.34
($50.05)
$ 6326%Add 12.57%2,711,949
LLYJoel Greenblatt 2013-12-31 Add0.11%$47.65 - $51.34
($50.05)
$ 6326%Add 201.79%141,121
LLYRay Dalio 2013-12-31 Add0.01%$47.65 - $51.34
($50.05)
$ 6326%Add 153.37%48,239
LLYVanguard Health Care Fund 2013-09-30 Add0.46%$49.92 - $54.96
($52.42)
$ 6320%Add 16.91%18,617,000
LLYCharles Brandes 2013-09-30 Add0.23%$49.92 - $54.96
($52.42)
$ 6320%Add 16.93%2,409,134
LLYPRIMECAP Management 2013-09-30 Add0.13%$49.92 - $54.96
($52.42)
$ 6320%Add 3.98%50,846,997
LLYDavid Dreman 2013-09-30 Buy 0.02%$49.92 - $54.96
($52.42)
$ 6320%New holding, 4290 sh.4,290
LLYRay Dalio 2013-09-30 Buy 0.01%$49.92 - $54.96
($52.42)
$ 6320%New holding, 19039 sh.19,039
LLYJohn Hussman 2013-09-30 Reduce-1.58%$49.92 - $54.96
($52.42)
$ 6320%Reduce -98.57%10,000
LLYJohn Hussman 2013-06-30 Add0.23%$49.06 - $58.33
($54.41)
$ 6316%Add 16.64%701,000
LLYPRIMECAP Management 2013-06-30 Add0.14%$49.06 - $58.33
($54.41)
$ 6316%Add 4.39%48,900,865
LLYJoel Greenblatt 2013-06-30 Add0.07%$49.06 - $58.33
($54.41)
$ 6316%Add 894.98%39,411
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LLY George Soros 2014-06-3050,44100.02New Buy
LLY David Dreman 2014-06-305,76900.03+11.33%
LLY PRIMECAP Management 2014-06-3057,102,8405.13.9-0.05%
LLY Charles Brandes 2014-06-302,686,2580.242-0.62%
LLY Mario Gabelli 2014-06-30120,0000.010.04-0.74%
LLY Dodge & Cox 2014-06-3035,27400-1.36%
LLY Vanguard Health Care Fund 2014-06-3021,982,7001.963.6-3.98%
LLY Joel Greenblatt 2014-06-307,74900.01-14.05%
LLY John Hussman 2014-06-305,00000.02-50%
LLY Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2014-07-29Sell250,000$63.03-0.05view
Mahony SusanSVP & Pres., Lilly Oncology 2014-07-28Sell2,065$63.3-0.47view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2014-07-25Sell10,000$63.79-1.24view
Mahony SusanSVP & Pres., Lilly Oncology 2014-07-25Sell30,000$63.9-1.41view
LILLY ENDOWMENT INC10% Owner 2014-07-01Sell235,000$62.31.12view
LILLY ENDOWMENT INC10% Owner 2014-06-25Sell245,000$62.680.51view
LILLY ENDOWMENT INC10% Owner 2014-06-20Sell230,000$61.622.24view
LILLY ENDOWMENT INC10% Owner 2014-06-20Sell230,000$61.552.36view
LILLY ENDOWMENT INC10% Owner 2014-06-16Sell200,000$58.737.27view
LILLY ENDOWMENT INC10% Owner 2014-06-05Sell190,000$59.535.83view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Eli Lilly is on the Right Track Jun 25 2014 
    John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
    Can Pfizer Make Up Its Loss? May 09 2014 
    Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
    Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
    These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 
    Forest Laboratories' Recovery Mar 18 2014 
    AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is Jan 15 2014 
    Guru Stocks at 52-Week Lows: IBM, T, TLK, LLY, GLD Dec 16 2013 

    More From Our Partners
    Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend Aug 27 2014 - BENZINGA

    More From Other Websites
    Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey Aug 27 2014
    [video] Facebook and Movado Downgraded, Deutsche Initiates Drugmakers Aug 27 2014
    Will This New Rating Help Eli Lilly (LLY) Stock Today? Aug 27 2014
    9:02 am Eli Lilly: New type 2 diabetes treatment Jardiance tablets for adults now available in U.S.... Aug 26 2014
    New type 2 diabetes treatment Jardiance® (empagliflozin) tablets for adults now available in U.S.... Aug 26 2014
    Lilly to Participate in Morgan Stanley 2014 Global Healthcare Conference Aug 25 2014
    Lilly to Participate in Morgan Stanley 2014 Global Healthcare Conference Aug 25 2014
    Eli Lilly Uncovers Positive Data from Ixekizumab Studies Aug 22 2014
    Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments Aug 21 2014
    Lilly psoriasis drug impresses; battle nears with Amgen, Novartis Aug 21 2014
    Lilly psoriasis drug impresses; battle nears with Amgen, Novartis Aug 21 2014
    Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies Aug 21 2014
    Lilly psoriasis drug fares well in late-stage test Aug 21 2014
    Lilly psoriasis drug fares well in late-stage test Aug 21 2014
    [$$] Lilly Psoriasis Treatment Meets Objectives Aug 21 2014
    Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies Aug 21 2014
    Eli Lilly-Boehringer's Insulin Drug Gets Tentative FDA Nod Aug 19 2014
    Eli Lilly insulin drug receives tentative U.S. approval Aug 18 2014
    FDA Grants Tentative Approval for Lilly and Boehringer Ingelheim's Basaglar™ (insulin glargine... Aug 18 2014
    Eli Lilly and Co's insulin drug receives tentative approval Aug 18 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK